ArticleHuman genetics2011
Direct-to-consumer testing: if consumers are not anxious, why are policymakers?
Article in Human genetics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Motivations, perceptions and impacts of direct-to-consumer genetic testing among users in Brazil.Journal of community genetics · 2025Article
- Associations between self-referral and health behavior responses to genetic risk information.Genome medicine · 2015Article
- Neither as harmful as feared by critics nor as empowering as promised by providers: risk information offered direct to consumer by personal genomics companies.Journal of community genetics · 2014Article
- Direct-to-Consumer Genetic Testing and Personal Genomics Services: A Review of Recent Empirical Studies.Current genetic medicine reports · 2013Article
- State of play in direct-to-consumer genetic testing for lifestyle-related diseases: market, marketing content, user experiences and regulation.The Proceedings of the Nutrition Society · 2013Article
- Harm, hype and evidence: ELSI research and policy guidance.Genome medicine · 2013Article
- Field of genes: an investigation of sports-related genetic testing.Journal of personalized medicine · 2012Article
- Psychological distress with direct-to-consumer genetic testing: a case report of an unexpected BRCA positive test result.Journal of genetic counseling · 2012Article
- Risky business: risk perception and the use of medical services among customers of DTC personal genetic testing.Journal of genetic counseling · 2012Article
- Health care providers and direct-to-consumer access and advertising of genetic testing in the United States.Genome medicine · 2011Article
- Direct-to-consumer personalized genomic testing.Human molecular genetics · 2011Review
- Genomic medicine and neurological disease.Human genetics · 2011Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Direct-to-consumer genetic testing continues to receive significant attention from both the popular press and policymakers. While the demand for these services has not, to date, been significant, it nevertheless seems likely that more and more individuals will be accessing DTC services. As a result, commentators have suggested that the DTC industry requires more oversight. A common rationale for policy action is that DTC services might cause undue anxiety. However, emerging evidence suggests that this is not the case. Indeed, it appears that genetic risk information has little impact on individual behavior or anxiety levels. Though more research is clearly needed, this type of research should inform the regulatory response to DTC services.
Indexed as
Identifiers
21479954What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.